For months, the humanoid narrative played out on its body: the gait, the hands, the parlour backflip. This week, the spotlight slid a notch inward — towards the machine's brain. Three announcements, seemingly unrelated, together tell one and the same shift: the robot's brain is becoming standardised like a chip, financed like a crypto asset, and sold like a platform. In other words, it is becoming an interchangeable commodity. And the detail that the folklore of the "record" has carefully buried comes down to a single figure: the valuation of the company at the centre of all this was halved along the way.
The brain has a new owner, and it makes stablecoins
The Series C round of NEURA Robotics, the humanoid maker based in Metzingen, Germany, closed in March 2026 at roughly €1 billion (about $1.2 billion). At its head you will not find an automation industrialist or a tech-friendly sovereign fund, but Tether Holdings, the issuer of the USDT stablecoin. For Tether, whose historic business is crypto backing, the deal fits an avowed diversification into AI, data centres and robotics. The financier of tomorrow's robotic brain first mints digital currency.
Around it, the round gathers a table of industrial and technology investors — Amazon, Qualcomm Ventures, Bosch, Schaeffler, along with affiliates of the Qatari billionaire Sheikh Hamad bin Jassim bin Jaber Al Thani. The presence of Qualcomm Ventures is no footnote: we will come back to it.
"Record": the word that hides a 50% markdown
The press release boasts a record amount. The metric that matters says something else. At the March 2026 closing, NEURA is valued at roughly €4 billion — whereas the estimates floated in November 2025 reckoned on €8 to €10 billion. A closing at that level would have made NEURA a "decacorn"; the valuation finally settled on is halved against that ambition.
The paradox is to be read on two axes at once. A year earlier, in January 2025, NEURA had raised €120 million in its Series B, with the Volvo Cars Tech Fund and L-Bank. So the stake is multiplied by nearly ten — and the valuation, in the same move, lopped in half against what was hoped for. You raise far more money while being worth far less than expected. The headline says "record"; the balance sheet says markdown.
Smartphone silicon in the robot's skull
On 9 March 2026, the second move falls into place. NEURA and Qualcomm Technologies announce a long-term strategic collaboration to develop next-generation robotics and physical-AI platforms. In concrete terms, the Dragonwing IQ10 Series processors — Qualcomm's mobile lineage — slot into NEURA's systems and serve as a reference design for autonomous mobile robots and humanoids. The robot's brain moves onto a phone chip.
The German trade press underlines the central argument: AI processing happens directly on the robot (edge), not in the cloud, to guarantee reflex reactions on safety-critical decisions. It is the "on-edge" sales pitch pushed to its conclusion: no latency, no network dependency.
But the point that closes the loop is not technical, it is capitalistic. Qualcomm Ventures is not merely the silicon partner: it is also a Series C investor. The brain supplier is a shareholder in the body maker. This pattern — the customer-shareholder, the supplier financing the very firm it equips — is nothing new in the sector; here it is reproduced on the Western side, in a closed circuit.
Neuraverse: you no longer sell a robot, you sell a marketplace
The third angle of the same move is the business model. In this collaboration, the Neuraverse platform, launched in June 2025, is used to simulate, train and validate the AI workloads embedded on the Dragonwing IQ10s before field deployment. The two companies announce that they want to build a global ecosystem and an open marketplace of physical-AI applications, on the principle of "develop once, deploy across several hardware architectures".
The shift is explicit: the object being sold is no longer a machine, it is a software infrastructure in which the robot becomes one terminal among others. App store and data, rather than sheet metal and motors.
At Figure, the bespoke code goes in the skip
The standardisation of the brain has a third manifestation, this one methodological. On 9 March 2026, the CEO of Figure AI, Brett Adcock, announces the deletion of 109,504 lines of hand-written C++ code, as part of the move to Helix 02. In its place, a single neural network dubbed "System 0", trained on more than 1,000 hours of human-motion data. The artisanal robotics expertise — the code written task by task, gesture by gesture — is liquidated in favour of a generic brain.
Figure claims that the 9 March demonstration, a robot tidying a living room, required no new algorithm and no specialised code: Helix 02 generalises to untrained scenarios via an end-to-end neural network. The promise is seductive. It remains a promise: Figure itself states that the Figure 03 was not ready for commercialisation at the time of the demonstration. The generic brain is nicely filmed; it is not yet a product.
Meanwhile, China ships hardware
The contrast with the other shore is sharp. RobotEra closed a strategic round of one billion yuan in March 2026 — its sixth round in under three years, for cumulative funding topping 3.5 billion yuan. AgiBot, for its part, reached 10,000 robots produced by the end of March 2026, against 5,168 shipped across the whole of 2025, and has declared 2026 its "Year 1 of deployment".
At the AW 2026 show in Seoul, this Chinese hardware made its Korean debut in live demonstration: AgiBot X2, AgiBot G2, Unitree G1, Leju Kuavo 4th generation Pro. While the West writes the narrative of the brain — the chip, the crypto, the platform — the East lines up units and makes them walk on a stand.
The metric to keep is not the one you are shown
The figure the sector waves about is the billion raised. The figure that tells the truth of the week is the minus 50% of valuation dressed up as a record — and the fact that whoever now holds the robot's brain makes stablecoins and phone chips, not robots. After the body became a commodity in February, it is the brain that is being standardised, securitised and sold like a marketplace. Interchangeable, this one too.